Resources

Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

 

To examine the relationship between the total number of months with an active buprenorphine prescription (retention) and the odds of an adverse outcome within the 12 months following an index non-f

Original research | 2024
Hospitals, Outcomes, Overdose, Substitution/OAT, Withdrawal, Treatment/recovery

The current study uses narrative analysis and framing theory to explore the series "Dopesick" (2021), discussing its portrayal of the people and themes involved in the USA opioid crisis.

Original research | 2024
Chronic pain, Opioids, Overdose, Stigma

This study explores perceptions and experiences of overdose among people who smoke drugs.

Original research | 2024
About PWUD, Illegal drugs, Overdose

This report by the Chief Medical Officer of Health for Ontario identifies trends in substance use related harms (especially tobacco and alcohol).

Report | 2023
2SLGBTQI+, About PWUD, Harm reduction, Indigenous, Policy/Regulatory
Guide or handbook | 2024
About PWUD, Barriers and enablers, Harm reduction, Housing, Naloxone, Stigma

This report maps out the strategies and practices that lie behind today’s most successful advocacy campaigns both in Canada and abroad.

Report | 2017
Advocacy, Equity, Legal system/law enforcement

To ensure optimal management of opioid use disorder (OUD), the updated 2024 CRISM National Guideline incorporates recent research, clinical insights, and input from individuals with lived experienc

Guidelines | 2024
Barriers and enablers, Clinical guidance, Harm reduction, Overdose, Peer/PWLLE program involvement, Stigma, Substitution/OAT, Treatment/recovery, Withdrawal, Wrap-around services

This study investigated patterns of prescription opioids dispensed in the 12 months before opioid-detected overdose death in Connecticut between May 8, 2016, and January 2, 2018, considering differ

Original research | 2024
About PWUD, Illegal drugs, Mortality, Opioids, Outcomes, Overdose, Sex/Gender

This paper describes a novel, volunteer physician-led interprofessional approach to identifying patients with opioid use disorder (OUD), initiating buprenorphine, and linking to office-based opioid

Report | 2024
Clinical guidance, Hospitals, Transitions in care/treatment, Substitution/OAT

Is coprescription of hydromorphone tablets or sustained-release oral morphine (opioid risk mitigation guidance [RMG]) and opioid agonist treatment (OAT) associated with subsequent OAT receipt?

Original research | 2024
About PWUD, Clinical guidance, Evidence base, Safer supply, Substitution/OAT, Transitions in care/treatment
Article | 2024
About PWUD, Safer supply, Mortality, Overdose

The objective of this study was to explore pharmacists’ attitudes, knowledge, and experiences in providing naloxone, dispensing buprenorphine, and selling nonprescription syringes following partici

Original research | 2024
About pharmacists, Barriers and enablers, Harm reduction, Illegal drugs, Naloxone, Stigma, Substitution/OAT

We provide a synopsis of the 2024 update of the 2018 National Guideline for the Clinical Management of Opioid Use Disorder, from the Canadian Research Initiative in Substance Matters (CRISM).

Guidelines | 2024
Clinical guidance, Harm reduction, Illegal drugs, Stigma, Substitution/OAT, Treatment/recovery, Withdrawal

This study examines how women's feelings of bodily agency while receiving MMT through Opioid Treatment Programs (OTPs) can impact treatment retention.

Original research | 2024
About PWUD, Advocacy, Crime, Illegal drugs, Legal system/law enforcement, Return to use, Sex/Gender , Stigma, Substitution/OAT, Treatment/recovery

In 2017, the Fraser Health Authority developed a training program for direct service providers designed to address the connection between provider stress and patient care—a mental health and resili

Original research | 2020
About prescribers, Mental health

This study investigates whether there is a community-level relationship between alcohol sales and opioid-related overdose deaths to inform the situating of harm reduction efforts in spaces most lik

Original research | 2024
About PWUD, Alcohol, Harm reduction, Opioids, Overdose

In 2018, the planned opening of a second Needle and Syringe Exchange Program (NSP) unit in Stockholm, Sweden, was stopped with reference to protests from the public.

Original research | 2024
Advocacy, Harm reduction, Injecting drugs, Stigma, Policy/Regulatory

The aim of this review was to classify impacts of climate change for people who use alcohol and other drugs (AoD), as reflected in peer reviewed literature.

Scoping review | 2024
About people who use drugs, Alcohol, Hospitals, Mental health, Substitution/OAT, Transitions in care/treatment, Withdrawal

The aim of this paper is to outline this position with reference to the evidence for harm reduction, and to argue that harm reduction needs to be implemented into mainstream healthcare settings to

Perspective | 2024
About nurses, Alcohol, Barriers and enablers, Drug checking, Harm reduction, Hospitals, Injecting drugs, Overdose, SCS/OPS, Wrap-around services
Slide deck | 2022
About prescribers, Barriers and enablers, Clinical guidance, Harm reduction, Hospitals, Ketamine, Opioids, Substitution/OAT, Withdrawal

Refine Your Search

Keywords
Format
Region